Brandywine Managers, LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison: Which Companies are Gaining and Losing Ground?

Brandywine Managers, LLC is a well-known investment firm that recently released their Q3 2022 and Q4 2022 13F holdings reports. 13F reports are a quarterly requirement for all institutional investment managers, and they provide valuable insight into the holdings of big investment firms like Brandywine. These reports offer a glimpse into which companies are gaining and losing ground in the current market landscape. In this article, we'll examine the most significant changes in Brandywine's holdings and what they could mean for the companies involved.

One of the most notable changes in Brandywine's holdings is the addition of UiPath Inc (PATH). In both Q3 and Q4 2022, Brandywine reported holding 434,841 shares of the company. The value of these shares increased slightly from $5,483,000 to $5,526,000. UiPath is a software company that provides "robotic process automation" tools for businesses. The company has seen impressive growth in the past year, with revenues growing by more than 70%. Brandywine's decision to invest in UiPath suggests that they see potential in the company's innovative technology.

Another interesting change in Brandywine's holdings is the increase in shares held for Moderna Inc (MRNA). In both Q3 and Q4 2022, Brandywine reported holding 9,510 shares of the company. However, the value of these shares increased from $1,125,000 in Q3 to $1,708,000 in Q4. Moderna is a biotech company that made headlines in 2020 for developing one of the first COVID-19 vaccines. The increasing value of Brandywine's holdings in Moderna suggests that they believe in the long-term potential of this company and its technology.

On the other hand, there are a few companies in which Brandywine decreased their holdings. CrowdStrike Holdings Inc (CRWD) is a cybersecurity company that saw a 34.1% decrease in value from Q3 to Q4 2022. Brandywine held 27,792 shares in Q3, but this number decreased to 28,680 in Q4. Interestingly, Brandywine also sold off all their shares in Ionis Pharmaceuticals Inc (IONS) and Varonis Systems Inc (VRNS) in Q4. These companies saw a decrease of 100% in total shares held from Brandywine.

There are other notable changes in Brandywine's holdings as well. For instance, Campbell Soup Co (CPB) saw a 20.4% increase in value from Q3 to Q4, while the value of Salesforce Inc (CRM) decreased by 7.8%. Overall, Brandywine seems to be placing more bets on exciting new companies like UiPath and Moderna while letting go of some of its shares in more established companies like Ionis Pharmaceuticals and Varonis Systems.

In conclusion, Brandywine's Q3 and Q4 2022 13F holdings reports provide valuable insight into the current state of the market for institutional investment firms. The addition of UiPath Inc and Moderna Inc to Brandywine's holdings suggests that they see potential in these innovative companies. Meanwhile, Brandywine's decision to sell off shares in companies like Ionis Pharmaceuticals and Varonis Systems may indicate a shift away from established players in the market. Overall, Brandywine's holdings provide a useful barometer of which companies are gaining and losing ground in today's rapidly changing market.